Tags

Type your tag names separated by a space and hit enter

Pharmacodynamics, Pharmacokinetics, and Kidney Distribution of Raw and Wine-Steamed Ligustri Lucidi Fructus Extracts in Diabetic Nephropathy Rats.
Molecules. 2023 Jan 12; 28(2)M

Abstract

The purpose of this study was to investigate differences in the pharmacodynamic, pharmacokinetic, and kidney distribution between Ligustri Lucidi Fructus (LLF) and wine-steamed Ligustri Lucidi Fructus (WLL) extracts in diabetic nephropathy (DN) rats. The DN rats were induced by high-fat-sugar diet (HFSD)/streptozotocin (STZ) regimen. For pharmacodynamics, the DN rats were treated with LLF and WLL extracts to assess the anti-diabetic nephropathy effects. For pharmacokinetics and kidney distribution, the concentrations of drugs (hydroxytyrosol, salidroside, nuezhenidic acid, oleoside-11-methyl ester, specnuezhenide, 1‴-O-β-d-glucosylformoside, G13, and oleonuezhenide) were determined. Regarding the pharmacodynamics, LLF and WLL extracts decreased the levels of blood glucose, serum creatinine (SCr), blood urea nitrogen (BUN), and 24-h urinary protein (24-h Upro) in DN rats. Furthermore, LLF and WLL extracts increased the level of high-density lipoprotein cholesterol (HDL-C); decreased the levels of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C); and reduced levels of pro-inflammatory cytokines (IL-1β, TNF-α, and IL-6) in DN rats. The anti-diabetic nephropathy effect of the WLL extract was better than that of the LLF extract. Regarding the pharmacokinetic and kidney tissue distribution, there were obvious differences in the eight ingredients between LLF and WLL extracts in DN rats. LLF and WLL extracts had protective effects on DN rats, while the WLL extract was better than the LLF extract regarding anti-diabetic nephropathy effects. The pharmacokinetic parameters and kidney distribution showed that wine-steaming could affect the absorption and distribution of the eight ingredients. The results provided a reasonable basis for the study of the clinical application and processing mechanism of LLF.

Authors+Show Affiliations

Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China. Shandong Provincial Collaborative Innovation Center for Quality Control and Construction of the Whole Industrial Chain of Traditional Chinese Medicine, Jinan 250355, China.School of Pharmacy, Shanxi University of Chinese Medicine, Jinzhong 030619, China.School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

36677849

Citation

Luan, Ruqiao, et al. "Pharmacodynamics, Pharmacokinetics, and Kidney Distribution of Raw and Wine-Steamed Ligustri Lucidi Fructus Extracts in Diabetic Nephropathy Rats." Molecules (Basel, Switzerland), vol. 28, no. 2, 2023.
Luan R, Zhao P, Zhang X, et al. Pharmacodynamics, Pharmacokinetics, and Kidney Distribution of Raw and Wine-Steamed Ligustri Lucidi Fructus Extracts in Diabetic Nephropathy Rats. Molecules. 2023;28(2).
Luan, R., Zhao, P., Zhang, X., Li, Q., Chen, X., & Wang, L. (2023). Pharmacodynamics, Pharmacokinetics, and Kidney Distribution of Raw and Wine-Steamed Ligustri Lucidi Fructus Extracts in Diabetic Nephropathy Rats. Molecules (Basel, Switzerland), 28(2). https://doi.org/10.3390/molecules28020791
Luan R, et al. Pharmacodynamics, Pharmacokinetics, and Kidney Distribution of Raw and Wine-Steamed Ligustri Lucidi Fructus Extracts in Diabetic Nephropathy Rats. Molecules. 2023 Jan 12;28(2) PubMed PMID: 36677849.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pharmacodynamics, Pharmacokinetics, and Kidney Distribution of Raw and Wine-Steamed Ligustri Lucidi Fructus Extracts in Diabetic Nephropathy Rats. AU - Luan,Ruqiao, AU - Zhao,Pan, AU - Zhang,Xuelan, AU - Li,Qinqing, AU - Chen,Xinfeng, AU - Wang,Ling, Y1 - 2023/01/12/ PY - 2022/11/06/received PY - 2022/12/09/revised PY - 2022/12/14/accepted PY - 2023/1/21/entrez PY - 2023/1/22/pubmed PY - 2023/1/25/medline KW - Ligustri Lucidi Fructus extract KW - diabetic nephropathy rats KW - kidney distribution KW - pharmacodynamics KW - pharmacokinetics KW - wine-steaming JF - Molecules (Basel, Switzerland) JO - Molecules VL - 28 IS - 2 N2 - The purpose of this study was to investigate differences in the pharmacodynamic, pharmacokinetic, and kidney distribution between Ligustri Lucidi Fructus (LLF) and wine-steamed Ligustri Lucidi Fructus (WLL) extracts in diabetic nephropathy (DN) rats. The DN rats were induced by high-fat-sugar diet (HFSD)/streptozotocin (STZ) regimen. For pharmacodynamics, the DN rats were treated with LLF and WLL extracts to assess the anti-diabetic nephropathy effects. For pharmacokinetics and kidney distribution, the concentrations of drugs (hydroxytyrosol, salidroside, nuezhenidic acid, oleoside-11-methyl ester, specnuezhenide, 1‴-O-β-d-glucosylformoside, G13, and oleonuezhenide) were determined. Regarding the pharmacodynamics, LLF and WLL extracts decreased the levels of blood glucose, serum creatinine (SCr), blood urea nitrogen (BUN), and 24-h urinary protein (24-h Upro) in DN rats. Furthermore, LLF and WLL extracts increased the level of high-density lipoprotein cholesterol (HDL-C); decreased the levels of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C); and reduced levels of pro-inflammatory cytokines (IL-1β, TNF-α, and IL-6) in DN rats. The anti-diabetic nephropathy effect of the WLL extract was better than that of the LLF extract. Regarding the pharmacokinetic and kidney tissue distribution, there were obvious differences in the eight ingredients between LLF and WLL extracts in DN rats. LLF and WLL extracts had protective effects on DN rats, while the WLL extract was better than the LLF extract regarding anti-diabetic nephropathy effects. The pharmacokinetic parameters and kidney distribution showed that wine-steaming could affect the absorption and distribution of the eight ingredients. The results provided a reasonable basis for the study of the clinical application and processing mechanism of LLF. SN - 1420-3049 UR - https://www.unboundmedicine.com/medline/citation/36677849/Pharmacodynamics_Pharmacokinetics_and_Kidney_Distribution_of_Raw_and_Wine_Steamed_Ligustri_Lucidi_Fructus_Extracts_in_Diabetic_Nephropathy_Rats_ DB - PRIME DP - Unbound Medicine ER -